U2AF1 and myelodysplastic syndrome: Numerous reports have confirmed that U2AF1 mutations in MDS and AML patients have associations with clinical features, such as age, gender, hemograms, bone marrow, karyotype, and other mutated genes, although some conclusions remain controversial.